Skip to main content
Company record · Pajottegem
Belgian companySituation normaleSociété en commandite simple

MARKOPHARMA

Enterprise number
0837.694.770
VAT number
BE0837694770
Registered office
Stevelberg 9A, 1541 Pajottegem
See the 2 companies at this address
Incorporated on
8 July 2011
Members only
Health score

Profile

Official information from the CBE (FPS Economy).

MARKOPHARMA is a Belgian company (Société en commandite simple) whose registered office is established at 1541 Pajottegem. Its main activity falls under “Autres activités de service de soutien aux entreprises nca” (NACE 82990).

Legal form
Société en commandite simple
Legal situation
Situation normale
Date of incorporation
8 July 2011

Secondary activities

1 additional NACE code declared.

Anti-money-laundering (AML) compliance

Is this activity subject to the Belgian anti-money-laundering obligations? An indicative assessment based on the declared NACE code.

Conditional obligationCompany service provider (potential)

Given its declared activity (“Autres activités de service de soutien aux entreprises nca”), MARKOPHARMA may be subject to anti-money-laundering obligations, under the conditions below.

Some business services fall under company service providers, which are obliged entities.

Conditions: Covered if the company professionally provides third parties with one of these services: taking part in the purchase or sale of shares in a company (other than a listed one), providing a statutory seat, or providing a commercial, postal or administrative address and related services (registered office). The AMLR (EU) 2024/1624 will widen this perimeter on 10 July 2027 (company formation, director mandates, nominee arrangements).

Applicable obligations
  • Identification and verification of the client's identity (KYC)
  • Identification of the ultimate beneficial owners (UBO register)
  • Assessment of money-laundering and terrorist-financing risks
  • Ongoing diligence and monitoring of transactions
  • Reporting suspicions to the CTIF
  • Retention of the documents and appointment of an AMLCO

Legal basis: art. 5, §1, 29° of the Act of 18 September 2017, referring to art. 3, 1° of the Act of 29 March 2018.

General information based on the declared NACE activity code; it is not legal advice. Whether the obligations actually apply depends on the activity effectively carried out.

Your risk analysis on this company

AML Company ran MARKOPHARMA through your due diligence questionnaire. Here are the first findings.

  • What is the geographic exposure of the client and of its transactions?

    Belgium only· Registered office published in the register

  • What is the company's solvency and lifecycle status?

    Trading, no proceedings· Legal situation published in the register

The rest of the analysis

Sanctions screening, politically exposed persons, ultimate beneficial owners, source of funds: AML Company runs them, documents them and keeps the proof in your file.

Run the full analysis

Log in

This preview is not a due diligence measure: it pre-qualifies questions from public data. Identifying the client and its ultimate beneficial owners requires documents collected and verified.

Establishments

1 active establishment unit declared with the CBE.

Implantation
Pajottegem

1 establishment · 1 municipality

Registered office1 establishment
Registered office
Stevelberg 9A
Map
Establishment2200.793.309
Stevelberg 9A
Map

Finances & financial health

Aggregate health score computed from the Altman Z″ model, completed with qualitative factors (age, regularity of filings, public alerts).

Zone Altman
Grade
Computed on

Financial data unavailable

This company's annual accounts carry no structured JSON (filings before 2022) or have not been published yet.

Health score and detailed factors

The grade, the score out of 100, the Altman Z″ zone and the list of public alerts are for members only.

Unlock

Notices in the Belgian Official Gazette

Official acts and notices: incorporation, changes to the articles, appointments, dissolutions.

Source: Belgian Official Gazette (FPS Justice). The links open the official PDFs.

Frequently asked questions about MARKOPHARMA

Quick answers on MARKOPHARMA's identity, contact details and official CBE information.

What is MARKOPHARMA's enterprise number (CBE)?
MARKOPHARMA's official enterprise number with the Crossroads Bank for Enterprises (CBE) is 0837694770. This unique number identifies the company with every Belgian administration.
What is MARKOPHARMA's VAT number?
MARKOPHARMA's intra-Community VAT number is BE0837694770. It is the CBE number prefixed with “BE” and enables trade within the European Union.
Where is MARKOPHARMA's registered office?
MARKOPHARMA's registered office is located at Stevelberg 9A, 1541 Pajottegem, Belgium. This address is the official one declared with the CBE.
What is MARKOPHARMA's legal form?
MARKOPHARMA is incorporated under the legal form “Société en commandite simple”. This form determines its legal and tax regime and its publication duties towards the Belgian Official Gazette.
When was MARKOPHARMA incorporated?
MARKOPHARMA was entered in the Crossroads Bank for Enterprises on 8 July 2011. This date is the official start of activity declared with the CBE.
Is MARKOPHARMA still active?
Yes, MARKOPHARMA is currently listed as an active company with the Crossroads Bank for Enterprises (CBE).
What is MARKOPHARMA's main activity?
MARKOPHARMA's declared main activity is: Autres activités de service de soutien aux entreprises nca (NACE code 82990). This NACE code officially classifies the company in the European nomenclature of economic activities.
How many establishments does MARKOPHARMA have?
MARKOPHARMA declares 1 establishment unit registered with the CBE, on top of its registered office.
Which official notices concern MARKOPHARMA?
3 official notices about MARKOPHARMA are available in the Belgian Official Gazette: incorporation, changes to the articles, appointments, dissolutions. Every one of these acts is listed on this page with a link to the official PDF.
Is MARKOPHARMA subject to anti-money-laundering obligations in Belgium?
It depends on the activity actually carried out. MARKOPHARMA (Company service provider (potential)) may be subject to anti-money-laundering obligations under certain conditions: Covered if the company professionally provides third parties with one of these services: taking part in the purchase or sale of shares in a company (other than a listed one), providing a statutory seat, or providing a commercial, postal or administrative address and related services (registered office). The AMLR (EU) 2024/1624 will widen this perimeter on 10 July 2027 (company formation, director mandates, nominee arrangements)..

Company timeline

Every dated event in the company's life, from filed accounts to notices published in the Belgian Official Gazette, in a single thread.

Timeline
3 events
Filter the timeline by event type

10 AI-analysed dimensions are not shown.

  1. 2019
    1. 1 July 2019Registered officeView the notice19086737
  2. 2017
    1. 5 January 2017Capital · SharesView the notice17003368
  3. 2011
    1. 20 July 2011IncorporationView the notice11111669

Registry record since 7 September 2026

The KBO publishes its changes as a monthly delta and never restates the past: our record starts on that date, not at the company's incorporation. No change recorded since that date. A missing row says nothing about the company, only about how far back our record goes.

AI insights · Pro AI plan

AI extraction of strategic AML data

The official notices in the Belgian Official Gazette are analysed by our AI engine to extract automatically the information that matters for your due diligence and your AML duties.

  • Legal life
  • Restructuring
  • Capital
  • Legal form
  • Incorporation
  • Directors
  • Beneficial owners
  • Registered office
  • Company name
  • Notarial deeds
AML Company

Step it up
Full analysis unlocked.

Create an account to unlock the detailed analysis: health score, full history, alerts and PDF exports.

    We respect your privacy

    We use cookies that are essential to running the site and, with your consent, anonymised audience-measurement cookies (hosted in the EU) to improve our services. Learn more.